Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 8.04
- Piotroski Score 6.00
- Grade Buy
- Symbol (GMED)
- Company Globus Medical, Inc.
- Price $84.89
- Changes Percentage (1.56%)
- Change $1.3
- Day Low $83.08
- Day High $85.01
- Year High $85.01
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/18/2025
- Fiscal Year End N/A
- Average Stock Price Target $79.00
- High Stock Price Target $96.00
- Low Stock Price Target $61.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.54
- Trailing P/E Ratio 120.59
- Forward P/E Ratio 120.59
- P/E Growth 120.59
- Net Income $122.87 M
Income Statement
Quarterly
Annual
Latest News of GMED
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Globus Medical Inc (GMED) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...
The company targeted cost redundancies and facility consolidations to drive EBITDA margins. NuVasive's sales force integration with Globus Medical's robotic systems is progressing well. The FDA warnin...
By Yahoo! Finance | 2 weeks ago -
Decoding Globus Medical Inc (GMED): A Strategic SWOT Insight
Globus Medical Inc (NYSE:GMED) excels in musculoskeletal and enabling technologies, showcasing strong growth post-merger with NuVasive. Financial data highlights increased net sales and expanded marke...
By Yahoo! Finance | 2 weeks ago -
Is Augmedix, Inc. (AUGX) the Best One-Dollar Stock to Buy Right Now?
An article discusses the performance of Augmedix, Inc. (NASDAQ:AUGX) compared to other one-dollar stocks. It highlights the company's financial growth, potential, and positive outlook, especially in t...
By Yahoo! Finance | 3 months ago
